These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 32960780)
1. Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer. Drpa G; Sutic M; Baranasic J; Jakopovic M; Samarzija M; Kukulj S; Knezevic J Radiol Oncol; 2020 Sep; 54(4):437-446. PubMed ID: 32960780 [TBL] [Abstract][Full Text] [Related]
2. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N; Cai Q Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392 [TBL] [Abstract][Full Text] [Related]
3. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
4. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277 [TBL] [Abstract][Full Text] [Related]
5. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer. Sakin A; Sahin S; Yasar N; Demir C; Arici S; Geredeli C; Cihan S Oncol Res Treat; 2019; 42(10):506-515. PubMed ID: 31336378 [TBL] [Abstract][Full Text] [Related]
6. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer. Liu D; Huang Y; Li L; Song J; Zhang L; Li W BMC Cancer; 2017 Dec; 17(1):882. PubMed ID: 29268698 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Suzuki R; Lin SH; Wei X; Allen PK; Welsh JW; Byers LA; Komaki R Radiother Oncol; 2018 Mar; 126(3):499-505. PubMed ID: 29398150 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related]
10. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer? Sert F; Cosgun G; Yalman D; Ozkok S Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415 [TBL] [Abstract][Full Text] [Related]
11. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer. Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852 [TBL] [Abstract][Full Text] [Related]
12. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study. Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer. Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672 [TBL] [Abstract][Full Text] [Related]
14. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy. Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy. Kutlu Y; Aydin SG; Bilici A; Oven BB; Olmez OF; Acikgoz O; Hamdard J Medicine (Baltimore); 2023 Apr; 102(15):e33432. PubMed ID: 37058061 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma. Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828 [TBL] [Abstract][Full Text] [Related]
19. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer. Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623 [TBL] [Abstract][Full Text] [Related]
20. Practical parameters that can be used for nutritional assessment in patients hospitalized in the intensive care unit with the diagnosis of chronic obstructive pulmonary disease: Prognostic nutritional index, neutrophil-to-lymphocyte, platelet-to-lymphocyte, and lymphocyte-to-monocyte ratio. Baldemir R; Cirik MÖ Medicine (Baltimore); 2022 Jun; 101(24):e29433. PubMed ID: 35713452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]